Form 4: Core Scientific Director Jarrod M. Patten Acquires 20,448 Shares Through Restricted Stock Unit Grant

Director Jarrod M. Patten of Core Scientific, Inc. acquired 20,448 shares of common stock through a restricted stock unit grant.

Summary

• Jarrod M. Patten, a director at Core Scientific, Inc., acquired 20,448 shares of common stock on January 27, 2025.
• The acquisition was in the form of a restricted stock unit (RSU) grant.
• The RSUs will vest in full on January 27, 2026, provided Mr. Patten continues to serve as a non-employee director.
• The price of the acquired shares was $0 at the time of the grant.

Sentiment

Score: 7

Explanation: The document reflects a standard equity grant to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The grant of restricted stock units to a director aligns their interests with the long-term success of the company.
• The vesting period encourages continued service and commitment from the director.

Future Outlook

The vesting of the RSUs is contingent on the director's continued service, indicating a commitment to the company's future.

Industry Context

This type of equity grant is a common practice for incentivizing board members in publicly traded companies, aligning their interests with shareholders.

Comparison to Industry Standards

• Equity grants, such as restricted stock units, are a standard form of compensation for directors in publicly listed companies.
• The vesting period of one year is also a common practice to ensure continued service and commitment from the director.
• Companies like Marathon Digital Holdings (MARA) and Riot Platforms (RIOT) also use similar equity-based compensation for their board members.

Stakeholder Impact

• The grant of RSUs to a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term performance.

Key Dates

Keywords

Core Scientific, Director, Jarrod M. Patten, Restricted Stock Units, RSU, Stock Grant, Beneficial Ownership, SEC Form 4